My watch list
my.bionity.com  
Login  
NEWS
Current news

Biotest opens new plasma collection centre in Vermillion, South Dakota

Biotest Pharmaceuticals Corporation (BPC), Boca Raton, USA, a 100% subsidiary of Biotest AG, Germany, a manufacturer of plasma proteins and biological products, announcea the addition of its newest plasma collection centre located at Vermillion, South Dakota, USA. The state-of-the-art facil ... more

Immunic acquires two promising drug development programs

Immunic AG (Immunic), a biotech company in Planegg-Martinsried near Munich, Germany, announced that it acquired 4SC AG’s (4SC) immunology portfolio, which includes two drug development programs and associated intellectual property and know-how. Immunic will continue all research and develop ... more

Vigilin, the lock keeper

Researchers have discovered a molecule in liver cells that controls the release of fat

ETH researchers have discovered a molecule in liver cells that controls the release of fat into the bloodstream. This “lock keeper” is present in large quantities in overweight people and leads indirectly to vascular narrowing. Anyone attending Munich’s famous Oktoberfest will know it can l ... more

Scientists discover how insect-borne viruses ‘suppress’ the immune system to cause disease

Arboviruses – viruses transmitted by insects such as mosquitoes – pose a considerable threat to both human and animal health. Despite that, not enough is known about the complex interactions between the virus and the host, particularly in the early stages of infection. Now, research led by ... more

Broadly neutralizing HIV antibodies pave the way for vaccine

A small number of people infected with HIV produce antibodies with an amazing effect: Not only are the antibodies directed against the own virus strain, but also against different sub-types of HIV that circulate worldwide. Researchers from the University of Zurich and University Hospital Zu ... more

Subsidiary Heidelberg Pharma contracts Celonic

Contract contains antibody cell line development and antibody production

WILEX AG, announced that its subsidiary Heidelberg Pharma, has signed an agreement with Celonic AG, Basel, Switzerland, a specialist in the development and manufacturing of biologics (CDMO). This agreement includes cell line development and the production of non-GMP and GMP (Good Manufactur ... more

Immunic successfully closes Series A financing round

Immunic AG (Immunic), a recently formed private start-up biotech company in Planegg-Martinsried near Munich, Germany, announced that it has closed its Series A financing round totaling EUR 17.5 million of preferred stock financing. The financing round was led by Life Sciences Partners V Coö ... more

Quick test to detect inflammation in diabetic patients developed

Scientists from Nanyang Technological University, Singapore (NTU Singapore) have developed a new kit that will allow doctors to find out within minutes if diabetic patients are suffering from inflammation. Current procedures require patients to wait for several hours for the results obtaine ... more

Custom-tailored strategy against glioblastomas

Glioblastomas are incurable malignant brain tumors. Usually the patients affected survive for only a few months. In addition, every tumor is quite different, which makes treatment very difficult. Researchers at the University of Bonn have now developed a completely new method as the basis f ... more

New insights into latent HIV infections

In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies t ... more

All news

Vigilin, the lock keeper

Researchers have discovered a molecule in liver cells that controls the release of fat

ETH researchers have discovered a molecule in liver cells that controls the release of fat into the bloodstream. This “lock keeper” is present in large quantities in overweight people and leads indirectly to vascular narrowing. Anyone attending Munich’s famous Oktoberfest will know it can l ... more

Scientists discover how insect-borne viruses ‘suppress’ the immune system to cause disease

Arboviruses – viruses transmitted by insects such as mosquitoes – pose a considerable threat to both human and animal health. Despite that, not enough is known about the complex interactions between the virus and the host, particularly in the early stages of infection. Now, research led by ... more

Controlling cell-fate decisions

Rafal Ciosk and his group at the FMI have identified an important link between the Notch signaling pathway and PRC2-mediated gene silencing. They showed that a fine balance between epigenetic silencing and signaling is crucial for cell-fate decisions. While this study has important implicat ... more

The architecture of odor perception

Olfactory glomeruli have a unique structure

Scientists at the Max Planck Institute for Chemical Ecology in Jena, Germany, have now quantified and mapped the functional units of the olfactory center in the brains of vinegar flies responsible for the perception of odors. They found out that the so-called olfactory glomeruli in the ante ... more

Ulrich Krauss to succeed Analytik Jena founder Klaus Berka as CEO

A change at the top for Analytik Jena AG. The Board member responsible for Sales and Marketing, Ulrich Krauss, will become the Company’s new Chief Executive Officer as of October 1, 2016. Klaus Berka, who founded Analytik Jena with two partners in April 1990 and has led the Company ever sin ... more

New knowledge about the building blocks of life

A study of an enzyme that helps build and repair DNA in living organisms increases our understanding of how these processes are controlled and how we can use this to combat infections. Chemists at the Faculty of Science at Lund University in Sweden, together with their colleagues in Umeå an ... more

Environmental DNA uncovers biodiversity in rivers

Researchers from UZH and Eawag have used “environmental DNA” to determine the biodiversity of a river. Previously, this involved collecting and identifying all the organisms living in it. Using environmental DNA, however, not only is it possible to characterize the river’s biodiversity, but ... more

Study finds potential new biomarker for cancer patient prognosis

To treat or not to treat? That is the question researchers at the Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) hope to answer with a new advance that could help doctors and their cancer patients decide if a particular therapy would be worth pursuing. Berkeley ... more

BMG LABTECH invests 4.5 million Euro in headquarters site expansion

Microplate reader manufacturer doubles its production area

BMG LABTECH has recorded a rapid increase in revenue over the past years. A new company building provides the additional capacity required for the company's anticipated business growth over the longer term. The expansion is a necessary response to the global demand for BMG LABTECH products ... more

Hitching a ride: misfiring drugs hit the wrong targets

It probably isn't surprising to read that pharmaceutical drugs don't always do what they're supposed to. Adverse side effects are a well-known phenomenon and something many of us will have experienced when taking medicines. Sometimes, these side effects can be caused when a drug hits the wr ... more

All news on bioanalytics

Biotest opens new plasma collection centre in Vermillion, South Dakota

Biotest Pharmaceuticals Corporation (BPC), Boca Raton, USA, a 100% subsidiary of Biotest AG, Germany, a manufacturer of plasma proteins and biological products, announcea the addition of its newest plasma collection centre located at Vermillion, South Dakota, USA. The state-of-the-art facil ... more

Immunic successfully closes Series A financing round

Immunic AG (Immunic), a recently formed private start-up biotech company in Planegg-Martinsried near Munich, Germany, announced that it has closed its Series A financing round totaling EUR 17.5 million of preferred stock financing. The financing round was led by Life Sciences Partners V Coö ... more

Controlling cell-fate decisions

Rafal Ciosk and his group at the FMI have identified an important link between the Notch signaling pathway and PRC2-mediated gene silencing. They showed that a fine balance between epigenetic silencing and signaling is crucial for cell-fate decisions. While this study has important implicat ... more

Rentschler doubles manufacturing capacity to address growing demand for biopharmaceuticals

Second significant expansion in one year

Rentschler Biotechnologie GmbH, a contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced the opening of a new facility with an capacity of two times 3,000 liters at the company’s site in Laupheim. This innovative Twin system consists of two stainl ... more

Treating pulmonary dysfunction in Pompe disease with gene therapy

Researchers at the University of Florida have successfully used gene therapy to treat patients with infantile onset Pompe disease, a progressive condition that severely compromises cardiopulmonary function in the first years of life. The team at UF’s Powell Center for Rare Disease Research ... more

Novozymes acquires Organobalance GmbH

Novozymes announces the acquisition of microbial research company Organobalance GmbH for an undisclosed amount. Germany-based Organobalance owns a large collection of microbial strains, some of which date back to the 1920s, and has strong capabilities in microbial screening and assay techno ... more

Singapore scientists develop DNA-altering technology to tackle diseases

Researchers in Singapore have developed a new protein that can alter DNA in living cells with much higher precision than current methods. The ability to alter DNA accurately will open more doors in the development of personalised medicine that could help to tackle human diseases that curren ... more

Precision medicine breakthrough for Chronic Myeloid Leukaemia

Scientists at the University of Glasgow have made a second significant breakthrough in the treatment of chronic myeloid leukaemia – using precision medicine to kill more than 90% of chronic myeloid leukaemia (CML) stem cells. The results are published today in the high impact journal Cancer ... more

Termination of lethal arrhythmia with light

A research team from the University of Bonn has succeeded for the first time in using light stimuli to stop life-threatening cardiac arrhythmia in mouse hearts. Furthermore, as shown in computer simulations at Johns Hopkins University, this technique could also be used successfully for huma ... more

Researchers investigate natural treatment for liver cancer

A UF Health researcher is studying a natural therapy for treating liver cancer, one of the leading causes of cancer-related deaths in the world. Thomas Schmittgen, Ph.D., a professor of pharmaceutics in the University of Florida College of Pharmacy, is identifying novel treatments and new w ... more

All news on biotechnology

Quick test to detect inflammation in diabetic patients developed

Scientists from Nanyang Technological University, Singapore (NTU Singapore) have developed a new kit that will allow doctors to find out within minutes if diabetic patients are suffering from inflammation. Current procedures require patients to wait for several hours for the results obtaine ... more

New insights into latent HIV infections

In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies t ... more

When the brain is high and dry

Previously, the cause of the illness was often unknown. Neurosurgeons in Bern have now simultaneously found the cause of spontaneous intracranial hypotension and the solution. Fluid protects our brains and spinal cords. If it is lost and can no longer be reproduced, the brain is literally h ... more

Cellular Mechanism Provides Explanation Model for Declining Memory Performance in Alzheimer's Disease

Loss of neuronal contacts impairs nerve cells that control activity of the hippocampus

Alzheimer’s disease triggers memory and learning disorders. To date, the causes are poorly understood. Now, researchers of the German Center for Neurodegenerative Diseases (DZNE) are shedding light on a possible mechanism: As Martin Fuhrmann and co-workers describe in the journal “Neuron,” ... more

Single crystal measures radioactivity

Affordable detectors for gamma radiation

A research team at Empa and ETH Zurich has developed single crystals made of lead halide perovskites, which are able to gage radioactive radiation with high precision. Initial experiments have shown that these crystals, which can be manufactured from aqueous solutions or low-priced solvents ... more

A mobile device developed by VTT detects irregular heartbeats

Helps to prevent cerebral infarctions

VTT Technical Research Centre of Finland has developed a mobile app and thumb-size device that help to prevent cerebral infarctions at an early stage, during asymptomatic atrial fibrillation. The mobile device, which detects arrhythmia (irregular heartbeat) has been tested with excellent re ... more

Merck announces 2016 recipients of € 1 Million grant for Multiple Sclerosis Innovation

Four research grants awarded out of 260 proposals from 45 countries

Merck, a leading science and technology company, today announced recipients of the fourth annual Grant for Multiple Sclerosis Innovation (GMSI) during a symposium at the 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in London. This year, ... more

MRI Guidance Shows Promise in Delivering Stem Cell Therapies

Working with animals, a team of scientists reports it has delivered stem cells to the brain with unprecedented precision by threading a catheter through an artery and infusing the cells under real-time MRI guidance. In a description of the work they express hope that the tests in anesthetiz ... more

Brainshake closes €3.5M to advance regulatory approval of blood analysis service

Finnish Brainshake has raised 3.5 million euros in Series A funding. The investment will be used to advance regulatory approval and internationalization of its blood analysis service. Brainshake’s blood analysis service provides more than 220 biomarkers from a single blood sample – 50 times ... more

Memory loss not enough to diagnose alzheimer's

Alzheimer's may also affect language, behavior or spatial judgment These patients often are not given an opportunity to be in Alzheimer's clinical trials Amyloid PET scan offers way to identify underlying disease and have more inclusive clinical trials Relying on clinical symptoms of memory ... more

All news on diagnostics

Thermo Fisher Scientific completes acquisition of FEI Company

Thermo Fisher Scientific Inc. announced that it has completed its acquisition of FEI Company, Inc. a manufacturer of high-performance electron microscopy, for $107.50 per share in cash, or a total purchase price of approximately $4.2 billion. The completion of the transaction follows the re ... more

Ulrich Krauss to succeed Analytik Jena founder Klaus Berka as CEO

A change at the top for Analytik Jena AG. The Board member responsible for Sales and Marketing, Ulrich Krauss, will become the Company’s new Chief Executive Officer as of October 1, 2016. Klaus Berka, who founded Analytik Jena with two partners in April 1990 and has led the Company ever sin ... more

Bluebee opens a new corporate office in Boston

Bluebee, a pioneer in cloud-based high performance genomics solutions, announced that it is expanding with a new corporate office in the Boston, MA. Over the year, Bluebee has established close relationships with major research and clinical labs in the United States, and expanding its opera ... more

Gerresheimer to sell Life Science research business

Gerresheimer and Chase Scientific Glass, Inc. are to sell their joint venture (51/49%) Kimble Chase to Duran Group, a portfolio company of One Equity Partners - Total transaction enterprise value of USD 131m for 100% of the business. In line with its strategy of focusing on packaging and de ... more

Tapping the unused potential of photosynthesis

Scientists from the University of Southampton have reengineered the fundamental process of photosynthesis to power useful chemical reactions that could be used to produce biofuels, pharmaceuticals and fine chemicals. Photosynthesis is the pivotal biological reaction on the planet, providing ... more

Gardner Denver Medical acquires ILS and Zinsser Analytic

Gardner Denver's Medical Group, a manufacturer of flow control solutions primarily for medical and laboratory sectors, announced the acquisition of Innovative Labor Systeme GmbH and Zinsser Analytic GmbH. “The talented team, technologies and know-how of ILS and ZA are highly complementary t ... more

A new way to display the 3-D structure of molecules

Researchers at the Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) and UC Berkeley have created a sort of nanoscale display case that enables new atomic-scale views of hard-to-study chemical and biological samples. Their work could help to reveal new structural d ... more

Merck Lifts Forecast Following Good Second Quarter

Organic sales growth in all regions

Merck reported a significant increase in sales in the second quarter of 2016 in comparison with the year-earlier period. EBITDA pre exceptionals also rose sharply. Owing to good business performance in the second quarter, Merck lifted its forecast for sales and EBITDA pre exceptionals. "We ... more

Water-resistant thanks to a biofilm

Mortar with an added bacterial film is highly resistant to water uptake

Moisture can destroy mortar over time – for example when cracks form as a result of frost. A team of scientists at the Technical University of Munich (TUM) has found an unusual way to protect mortar from moisture: When the material is being mixed, they add a biofilm – a soft, moist substanc ... more

BioTek Instruments embarks on major site expansion

BioTek Instruments celebrated the start of a $4 million, 22,000 square foot facility expansion during a company-wide event on Monday, July 18, featuring honorable guests Vermont Senator Patrick Leahy, Congressman Peter Welch, Governor Peter Shumlin, and Lt. Governor Phil Scott. The increase ... more

All news on lab technology

Biotest opens new plasma collection centre in Vermillion, South Dakota

Biotest Pharmaceuticals Corporation (BPC), Boca Raton, USA, a 100% subsidiary of Biotest AG, Germany, a manufacturer of plasma proteins and biological products, announcea the addition of its newest plasma collection centre located at Vermillion, South Dakota, USA. The state-of-the-art facil ... more

Immunic acquires two promising drug development programs

Immunic AG (Immunic), a biotech company in Planegg-Martinsried near Munich, Germany, announced that it acquired 4SC AG’s (4SC) immunology portfolio, which includes two drug development programs and associated intellectual property and know-how. Immunic will continue all research and develop ... more

Broadly neutralizing HIV antibodies pave the way for vaccine

A small number of people infected with HIV produce antibodies with an amazing effect: Not only are the antibodies directed against the own virus strain, but also against different sub-types of HIV that circulate worldwide. Researchers from the University of Zurich and University Hospital Zu ... more

Subsidiary Heidelberg Pharma contracts Celonic

Contract contains antibody cell line development and antibody production

WILEX AG, announced that its subsidiary Heidelberg Pharma, has signed an agreement with Celonic AG, Basel, Switzerland, a specialist in the development and manufacturing of biologics (CDMO). This agreement includes cell line development and the production of non-GMP and GMP (Good Manufactur ... more

Custom-tailored strategy against glioblastomas

Glioblastomas are incurable malignant brain tumors. Usually the patients affected survive for only a few months. In addition, every tumor is quite different, which makes treatment very difficult. Researchers at the University of Bonn have now developed a completely new method as the basis f ... more

Evotec and Bayer partner to develop new treatments to fight kidney diseases

Evotec AG announced that Evotec and Bayer have entered into a five-year, multi-target research partnership. The goal is the development of multiple clinical candidates for the treatment of kidney diseases such as chronic kidney disease in diabetes patients. Both companies will contribute no ... more

Study sheds light on treating cancer

Using light to target and kill cancer cells alternatively without surgery

A new study, affiliated with UNIST has presented a natural, alternative, and holistic cancer treatment that uses light to selectively wipe out cancerous cells without harming surrounding tissue. With further research, this novel method might eventually be used to treat tumors in humans. Thi ... more

FDA grants accelerated approval to first drug for Duchenne muscular dystrophy

The U.S. Food and Drug Administration approved Exondys 51 (eteplirsen) injection, the first drug approved to treat patients with Duchenne muscular dystrophy (DMD). Exondys 51 is specifically indicated for patients who have a confirmed mutation of the dystrophin gene amenable to exon 51 skip ... more

FDA approves new five-year-contraceptive of Bayer

The U.S. Food and Drug Administration (FDA) has approved Bayer AG’s new low dose levonorgestrel-releasing intrauterine system (LNG-IUS) which will be marketed in the US under the brand name Kyleena™. Kyleena releases the lowest daily dose of the hormone levonorgestrel in an intrauterine sys ... more

Lanthio Pharma expands management team

The Dutch biopharmaceutical company Lanthio Pharma B.V., a wholly owned subsidiary of MorphoSys AG, announced the appointment of Axel Mescheder, M.D. as Chief Medical Officer (CMO). Dr. Heinz Schwer, Chief Executive Officer of Lanthio Pharma, commented: "We are very pleased to welcome Axel ... more

All news on pharma

Biotest opens new plasma collection centre in Vermillion, South Dakota

Biotest Pharmaceuticals Corporation (BPC), Boca Raton, USA, a 100% subsidiary of Biotest AG, Germany, a manufacturer of plasma proteins and biological products, announcea the addition of its newest plasma collection centre located at Vermillion, South Dakota, USA. The state-of-the-art facil ... more

Vigilin, the lock keeper

Researchers have discovered a molecule in liver cells that controls the release of fat

ETH researchers have discovered a molecule in liver cells that controls the release of fat into the bloodstream. This “lock keeper” is present in large quantities in overweight people and leads indirectly to vascular narrowing. Anyone attending Munich’s famous Oktoberfest will know it can l ... more

Scientists discover how insect-borne viruses ‘suppress’ the immune system to cause disease

Arboviruses – viruses transmitted by insects such as mosquitoes – pose a considerable threat to both human and animal health. Despite that, not enough is known about the complex interactions between the virus and the host, particularly in the early stages of infection. Now, research led by ... more

Broadly neutralizing HIV antibodies pave the way for vaccine

A small number of people infected with HIV produce antibodies with an amazing effect: Not only are the antibodies directed against the own virus strain, but also against different sub-types of HIV that circulate worldwide. Researchers from the University of Zurich and University Hospital Zu ... more

Quick test to detect inflammation in diabetic patients developed

Scientists from Nanyang Technological University, Singapore (NTU Singapore) have developed a new kit that will allow doctors to find out within minutes if diabetic patients are suffering from inflammation. Current procedures require patients to wait for several hours for the results obtaine ... more

Custom-tailored strategy against glioblastomas

Glioblastomas are incurable malignant brain tumors. Usually the patients affected survive for only a few months. In addition, every tumor is quite different, which makes treatment very difficult. Researchers at the University of Bonn have now developed a completely new method as the basis f ... more

New insights into latent HIV infections

In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies t ... more

Fatal tombstones, goat men and "mirror scratching"

Ig Noble Prizes awarded

The laureates are once again awarded for their on the first, and often also on further, glance(s) nonsense studies in several areas of research. This is a short overview. Reproduction Prize (Egypt): The late Ahmed Shafik, for studying the effects of wearing polyester, cotton, or wool trou ... more

Modeling study sheds light on disease eradication

Diseases evolve in response to treatment, frustrating efforts to eradicate them. A new study shows how evolution, population dynamics, and economic factors interact, providing new insight that could help inform efforts to control diseases like malaria. Efforts to eradicate a disease are li ... more

Sleeping sickness can also be transmitted and spread via the skin

Scientists have made an important new discovery in the study of Human African Trypanosomiasis, more commonly known as African sleeping sickness. The findings could have a major impact on the way the disease is diagnosed, treated and potentially eradicated.   The team of researchers, from t ... more

All news on healthcare
News by department
News according to country
News archive
Newsletters

bionity.com Newsletter

The bionity.com newsletter keeps you informed about the current events in the fields of biotechnology, life sciences and medicine with news, products, company profiles and technical information.
Current edition

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE